Despite focused efforts to improve the diversity of clinical trials, representation in research into head and neck cancer has become less equitable over the past decade, according to retrospective ...
The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, but risk is elevated in the first year of treatment, according to a ...
ENT Partners, LLC, a leading Physician Practice Management Company (PPMC) specializing in the Ear, Nose, Throat, Facial Plastics & Sleep industry, announced its continued expansion in the Baltimore ...